Day: February 14, 2024

Equus Subsidiary Morgan E&P Provides Update on Reserves

Written by Customer Service on February 14, 2024. Posted in Public Companies.

Certified Proven Reserve PV10 Value Up 135% HOUSTON, Feb. 14, 2024 (GLOBE NEWSWIRE) — Equus Total Return, Inc. (NYSE: EQS) (“Equus”) today announced that its wholly-owned subsidiary Morgan E&P, LLC (“Morgan”), has received from Cawley, Gillespie & Associates, Inc. (“CG&A”) an updated reserve estimate as of January 1, 2024. Morgan continues to acquire mineral rights in the Bakken/Three Forks formation in the Williston Basin of North Dakota, and on December 18, 2023, announced an increase in its acreage in this area from 4,747.52 net acres to 5,976.84 net acres, an increase of 1,229.32 net acres, or approximately 25.9%. Morgan engaged the petroleum engineering firm of CG&A to review and provide an updated reserve analysis of this asset using the December 29, 2023 NYMEX strip pricing. Using...

Silo Pharma’s SP-26 Ketamine Implant Demonstrates Successful Drug Delivery

Written by Customer Service on February 14, 2024. Posted in Public Companies.

Initial indications target fibromyalgia and chronic pain Loaded and encapsulated drug maintains structural stability as implantable treatment SARASOTA, FL, Feb. 14, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today provided a positive update on SP-26, its novel time-released, dose-controlled formulation of ketamine initially targeted for fibromyalgia. A pre-clinical research study is underway involving analytical testing services and small batch proof-of-concept extrusion trials to determine drug release and stability. In recent testing, SP-26 polymer implants were blended with ketamine hydrochloride (ketamine HCL) in two...

TIAN RUIXIANG Holdings Ltd’s Subsidiary Enters into Sale and Purchase Agreement for Licensed Insurance Broker in Hong Kong

Written by Customer Service on February 14, 2024. Posted in Public Companies.

BEIJING, Feb. 14, 2024 (GLOBE NEWSWIRE) — TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the “Company”), a China-based insurance broker conducting business through its variable interest entity in China, today announced that TRX HongKong Investment Limited (“TRX HongKong”), a wholly-owned subsidiary of the Company, has entered into a sale and purchase agreement (the “SPA”) to acquire Peak Consulting Services Limited (the “Target”) from Yuefu Company Limited (the “Vendor”), the sole shareholder of the Target. The Target is a licensed insurance brokerage in Hong Kong. This strategic acquisition represents a milestone in the Company’s business to expand into the Hong Kong insurance brokerage market. Pursuant to the SPA, the proposed acquisition (the “Acquisition”) is conditioned upon, among other things, the completion...

Invesco Ltd: Form 8.3 – DS Smith PLC Public dealing disclosure

Written by Customer Service on February 14, 2024. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION (a) Full name of discloser: Invesco Ltd. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Smith (DS) plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior to...

Progressive Reports January 2024 Results

Written by Customer Service on February 14, 2024. Posted in Earnings Releases And Operating Results.

MAYFIELD VILLAGE, OHIO, Feb. 14, 2024 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for the month ended January 31, 2024: January(millions, except per share amounts and ratios; unaudited) 2024Net premiums written $ 5,495.7Net premiums earned $ 5,386.0Net income $ 700.7Per share available to common shareholders $ 1.18Total pretax net realized gains (losses) on securities $ 16.6Combined ratio – current year 87.3 – prior year 96.0Average diluted equivalent common shares 587.3In October 2023, we converted our monthly accounting closing calendar to align with the Gregorian calendar. We do not expect that this change will have a material impact on our reported quarterly and annual underwriting results but it may impact our year-over-year...

Outlook Therapeutics® Reports Financial Results for First Quarter Fiscal Year 2024 and Provides Corporate Update

Written by Customer Service on February 14, 2024. Posted in Earnings Releases And Operating Results.

NORSE EIGHT underway with first subject dosed and additional clinical sites beginning enrollment Continue to expect planned resubmission of the ONS-5010 Biologics License Application (BLA) by the end of CY2024 Anticipate review decision from European regulators in the first half of CY2024ISELIN, N.J., Feb. 14, 2024 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve regulatory approval for the first ophthalmic formulation of bevacizumab for the treatment of retinal diseases, today announced financial results for first quarter fiscal year 2024 and provided a corporate update. “We are proud of the recent progress our team has made. In January 2024, we received confirmation that the FDA has reviewed and agreed upon the NORSE EIGHT trial protocol pursuant to the SPA they...

Freddie Mac Announces Fourth Quarter and Full-Year 2023 Financial Results

Written by Customer Service on February 14, 2024. Posted in Earnings Releases And Operating Results.

MCLEAN, Va., Feb. 14, 2024 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today reported its Fourth Quarter and Full-Year 2023 financial results and filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission. The company’s Form 10-K and earnings press release, along with the Fourth Quarter 2023 financial results supplement are available now on the Investor Relations page of the company’s website. The company will hold a call at 9 a.m. Eastern Time (ET) today, February 14, 2024, to share its results with the media. The call will be concurrently webcast, and the replay will be available on the company’s website for approximately 30 days. Freddie Mac’s mission is to make home possible for families across the nation. We promote liquidity, stability, affordability and equity in the housing market throughout...

Conduent Reports Fourth Quarter and Full Year 2023 Financial Results

Written by Customer Service on February 14, 2024. Posted in Earnings Releases And Operating Results.

Key Q4 and Full Year 2023 HighlightsRevenue and Adj. Revenue(1): Q4 $953M / FY $3,722M Pre-tax Income (Loss): Q4 $(4)M / FY $(332)M Adj. EBITDA Margin(1): Q4 10.8% / FY 10.2% New business signings ACV(2): Q4 $152M / FY $639M Net ARR Activity Metric(2) (TTM): $62MFLORHAM PARK, N.J., Feb. 14, 2024 (GLOBE NEWSWIRE) — Conduent (NASDAQ: CNDT), a global technology-led business process solutions company, today announced its fourth quarter and full year 2023 financial results. Cliff Skelton, Conduent President and Chief Executive Officer stated, “Our Q4 results contributed to a strong finish to 2023, with Adjusted Revenue, Adjusted EBITDA and Adjusted EBITDA Margin exceeding our previously described Outlook for 2023. While we experienced some macroeconomic headwinds in our Commercial sales efforts, our Total Contract Value sales were...

The Vita Coco Company to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

Written by Customer Service on February 14, 2024. Posted in Earnings Releases And Operating Results.

NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) — The Vita Coco Company, Inc. (NASDAQ: COCO) (“Vita Coco” or the “Company”), a leading high-growth platform of better-for-you beverage brands, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023 on Wednesday, February 28, 2024 before market open. The Company will host a conference call and webcast to discuss these results at 8:30 a.m. ET on the same day. To participate in the live earnings call and question and answer session, please register at https://register.vevent.com/register/BIe6dcf1fadce5486fbe3f13b835deeed7 and dial-in information will be provided directly to you. The live audio webcast will be accessible in the “Events” section of the Company’s Investor Relations website at https://investors.thevitacococompany.com/....

Great Lakes Reports Fourth Quarter and Full Year 2023 Results

Written by Customer Service on February 14, 2024. Posted in Earnings Releases And Operating Results.

Fourth quarter net income of $21.6 millionFourth quarter adjusted EBITDA of $40.8 millionFull year net income of $13.9 millionFull year adjusted EBITDA of $73.0 millionRecord dredging backlog of $1.04 billion at December 31, 2023 HOUSTON, Feb. 14, 2024 (GLOBE NEWSWIRE) — Great Lakes Dredge & Dock Corporation (“Great Lakes” or the “Company”) (Nasdaq: GLDD), the largest provider of dredging services in the United States, today reported financial results for the quarter and year ended December 31, 2023. Fourth Quarter 2023 ResultsRevenue was $181.7 million Total operating profit was $30.5 million Net income was $21.6 million (includes $5.6 million gain related to the termination of an offshore wind contract) Adjusted EBITDA was $40.8 million (includes $7.4 million gain related to the termination of an offshore wind contract)Full...

Day: February 14, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals